JEADV Clinical Practice, EarlyView.ABSTRACT Skin changes such as xerosis and pruritus are common complications among diabetes patients and may lead to serious adverse events such as diabetic foot syndrome and amputations. Evidence suggests that daily application of optimal skincare, including gentle cleansers and moisturizers, may help improve skin barrier function, preventing ...
Robert S. Kirsner +5 more
wiley +1 more source
PD-1 blockade with nivolumab in relapsed or refractory Hodgkin's lymphoma.
New England Journal of Medicine, 2015 S. Ansell +18 more
semanticscholar +1 more source
Remembering the forgotten child: the role of immune checkpoint inhibition in patients with human immunod eficiency virus and cancer. [PDF]
, 2019 Patients with human immunodeficiency virus (HIV) infection have a high risk of developing virally-mediated cancers. These tumors have several features that could make them vulnerable to immune checkpoint inhibitors (ICIs) including, but not limited to ...
Adashek, Jacob J +3 more
core
Categorization of Reasons for Hospitalizations in Patients With Cutaneous T‐Cell Lymphoma
JEADV Clinical Practice, EarlyView.ABSTRACT Background Cutaneous T‐cell lymphomas (CTCL) can significantly impact patients' quality of life as well as impose a substantial healthcare burden due to their complex management and risk of hospitalization. Objectives This study aimed to identify factors associated with hospital admissions among patients with CTCL and to characterize the ...
Geetha Gowda +6 more
wiley +1 more source
The NF-κB subunit c-Rel regulates Bach2 tumour suppressor expression in B-cell lymphoma
, 2016 The REL gene, encoding the NF-κB subunit c-Rel, is frequently amplified in B-cell lymphoma and functions as a tumour-promoting transcription factor. Here we report the surprising result that c-rel–/– mice display significantly earlier lymphomagenesis in ...
Bacon, C.M. +9 more
core +1 more source
The Kaohsiung Journal of Medical Sciences, EarlyView.ABSTRACT Diffuse large B‐cell lymphoma (DLBCL) is the most common non‐Hodgkin lymphoma and is an aggressive and highly heterogeneous tumor. Kaempferitrin (KPF) is a natural flavonoid glycoside that exerts a protective role in multiple human tumors. However, the impact of KPF on DLBCL remains unclear.
Han‐Shuo Zhang +3 more
wiley +1 more source
Beyond PD‐1/PD‐L1: New Immune Checkpoints and Therapeutic Combinations in Cancer Immunotherapy
Medicine Bulletin, EarlyView.ABSTRACT Recently, immune checkpoint inhibitors (ICIs), particularly PD‐1/PD‐L1 and CTLA‐4 inhibitors, have revolutionized cancer treatment, significantly improving survival rates for various malignancies. However, ICI therapies targeting single checkpoints on T cells still face numerous challenges, such as low response rates and post‐treatment ...
Yangyang Li, Zizhen Kang, Yanyun Du
wiley +1 more source
CD20 positivity in classical Hodgkin′s lymphoma: Diagnostic challenge or targeting opportunity
Indian Journal of Pathology and Microbiology, 2009 Background: It is now well established that Hodgkin cells are clonal B cells with a CD30 and CD15 phenotype. However, on immunohistochemistry, in our experience and the experience of others, CD20 positivity in an otherwise typical classical Hodgkin ...
Barakzai Muhammad, Pervez Shahid
doaj
PF469 TISLELIZUMAB (BGB‐A317) FOR RELAPSED/REFRACTORY CLASSICAL HODGKIN LYMPHOMA: UPDATED FOLLOW‐UP EFFICACY AND SAFETY RESULTS FROM A PHASE 2 STUDY [PDF]
, 2019 Yongping Song +17 more
openalex +1 more source
A predictive model for aggressive non-Hodgkin's lymphoma.
New England Journal of Medicine, 1993 M. Shipp +26 more
semanticscholar +1 more source